首页工具

登录

搜索结果

Search Results for " colorectal cancer (crc) "

21

抑制剂 & 化合物

2

天然产物

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T0459	Sulindac Arthrocine,MK-231,舒林酸,Clinoril,Sulindac sulfoxide	COX; Autophagy	Autophagy; Immunology/Inflammation; Neuroscience
	Sulindac (Sulindac sulfoxide) 是一种非甾体类抗炎剂，可抑制COX-2的活性，也可抑制 COX-2 的过表达。它是一种亚磺酰基茚衍生物前药，具有潜在的抗肿瘤活性。
T9556	TNIK-IN-3	Wnt/beta-catenin	Cytoskeletal Signaling; Stem Cells
	TNIK-IN-3 is a highly potent and orally active inhibitor of Traf2- and Nck-interacting protein kinase (TNIK). It exhibits a strong selectivity for TNIK with an IC50 value of 0.026 μM. Additionally, TNIK-IN-3 demonstrates inhibitory activity against Flt4 (IC50 = 0.030 μM), Flt1 (IC50 = 0.191 μM), and DRAK1 (IC50 = 0.411 μM). This compound holds potential for carrying out research on colorectal cancer (CRC) [1].
T77519	FC-116 FC116	Apoptosis; Microtubule Associated	Apoptosis; Cytoskeletal Signaling
	FC-116 是一种有效的 Tubulin 抑制剂，具有抗肿瘤活性，抑制小鼠体内肿瘤的生长。FC-116 诱导大肠癌 (CRC) 细胞凋亡，可促进蛋白降解。
T9901A-004	Labetuzumab IMMU-14,hMN-14,IMMU-100
	Labetuzumab (hMN-14) 是一种人源化抗癌胚抗原 (CEA) 单克隆抗体，具有抗癌活性，可抑制肿瘤生长，可用于研究甲状腺癌和结直肠癌 (CRC)。
T72068	SFI003	Apoptosis; ROS	Apoptosis; Immunology/Inflammation
	SFI003是一种新型SRSF3抑制剂，通过调节SRSF3 / DHCR24 / ROS 轴对结直肠癌发挥抗癌活性，通过SRSF3 / DHCR24 /活性氧（ROS）轴驱动CRC 细胞凋亡。
T76890	Petosemtamab MCLA 158	EGFR	Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors
	Petosemtamab (MCLA 158) 是一种高效的抗 EGFR (Kd: 0.22 nM) 和抗 LGR5 (Kd: 0.86 nM) 单克隆抗体。Petosemtamab 促使 LGR5+ 癌细胞中的 EGFR 信号传导中断和受体分解。Petosemtamab 可用于头颈部鳞状细胞癌 (HNSCC)、转移性结直肠癌 (CRC) 等实体瘤的研究。
T21567L	Cyclosomatostatin Acetate Cyclosomatostatin Acetate （84211-54-1 Free base）	Somatostatin	GPCR/G Protein
	Cyclosomatostatin Acetate 是有效的生长抑素受体拮抗剂。Cyclosomatostatin Acetate 在直肠癌 (CRC) 细胞中可以抑制 SSTR1的信号传导，并降低结细胞增殖、ALDH+ 细胞群体大小和球形成。
T27163	DHNQ
	DHNQ is a novel inhibitor of the PI3K enzyme activity and transcriptional as well as translational expression levels in colorectal cancer (CRC).
T36742	CDK5 inhibitor 20-223 CDK5 inhibitor 20-223
	CDK5 inhibitor 20-223, a potent inhibitor of CDK2 and CDK5, demonstrates IC50 values of 6.0 nM and 8.8 nM, respectively. It serves as an effective agent against colorectal cancer (CRC)[1].
T71624	GB1874
	GB1874 inhibitor of the Wnt pathway that targets the β-cat-TCF4 PPI. GB1874 also affected the proliferation and stemness of Wnt-addicted colorectal cancer (CRC) cells in vitro. Encouragingly, GB1874 inhibited the growth of CRC tumor xenografts in vivo, thus demonstrating its potential for further development into therapeutics against Wnt-associated cancer indications.
T38519	YB-0158 Wnt pathway inhibitor 2,YB-0158
	YB-0158 (Wnt pathway inhibitor 2) is a powerful peptidomimetic compound that effectively targets colorectal cancer stem cells (CSCs) by disrupting the interaction between Sam68 and Src proteins. This compound acts as a reverse-turn agent, inducing apoptosis in CRC cells and displaying strong anti-cancer activities.
T73391	BLM-IN-2
	BLM-IN-2是一种针对布鲁姆氏综合征蛋白(BLM)的抑制剂，IC50为0.8 μM。该化合物能够有效抑制结直肠癌(CRC)细胞的增殖、侵袭、诱导细胞周期阻滞及凋亡，因此适用于结直肠癌的研究。
T36676	Rineterkib hydrochloride
	Rineterkib hydrochloride (compound B) is an orally active RAF and ERK1/2 inhibitor in the treatment of a proliferative disease characterized by activating mutations in the MAPK pathway. The activity is particularly related to the treatment of KRAS-mutant NSCLC, BRAF-mutant NSCLC, KRAS-mutant pancreatic cancer, KRAS-mutant colorectal cancer (CRC) and KRAS-mutant ovarian cancer[1]. ERK-IN-1 (compound B) (50, 75 mg/kg, p.o., qd/q2d, 27 days) treatment significantly reduces the tumor volume in the C...
T75842	Cyclosomatostatin TFA
	Cyclosomatostatin TFA 作为一种有效的生长抑素(SST)受体拮抗剂，在直肠癌(CRC)细胞中通过抑制1型生长抑素受体(SSTR1)的信号传导，有效降低结细胞增殖、ALDH+细胞群体的大小以及球形成。
T60030	NCT02
	NCT02 是一种细胞周期蛋白 K 降解剂，可诱导细胞周期蛋白 K (CCNK) 的泛素化和 CCNK 及其复合物 CDK12 的蛋白酶体降解。NCT02具有研究转移性结直肠癌 (CRC) 的潜力。
T82414	Favezelimab MK-4280
	Favezelimab（MK-4280）为人源化抗LAG-3单克隆抗体，能够抑制LAG-3与其配体MHC II类结合。该抗体联合PD-L1抑制剂Pembrolizumab在结直肠癌（CRC）治疗研究中展现出应用前景。
T61585	Sulindac sodium
	Sulindac (sodium) (MK-231) 是一种非甾体抗炎剂，具有口服活性。Sulindac (sodium) 用于减轻疼痛，肿胀和关节僵硬的关节炎。Sulindac 还用于脊柱关节炎、痛风性关节炎的研究。Sulindac (sodium) 作为一种免疫调节剂，可通过阻断 NF-κB 信号通路下调 PD-L1，调节 pMMR CRC 对抗 PD-L1 免疫治疗的应答，抑制结直肠癌 CRC 的发生发展。 Sulindac 还可通过下调 SIRT1 抑制 TGF-β1-诱导的 EMT，抑制肺癌细胞的迁移和侵袭。
T61896	hCAIX-IN-12
	hCAIX-IN-12 是有效的hCAIX 抑制剂，抑制 CAIX 和 CAII 的IC50分别为 0.74 和 10.78 μM。hCAIX-IN-12 抗细胞增殖并诱导凋亡 (apoptosis)。hCAIX-IN-12 可以增加ROS 的产生。hCAIX-IN-12在结直肠癌（CRC）中具有研究潜力。
T69985	Lifirafenib HCl
	Lifirafenib, also known as Beigene-283, is a Novel potent and selective RAF Kinase and EGFR inhibitor. BGB-283-displays Potent Antitumor Activity in B-RAF Mutated Colorectal Cancers. In vitro, BGB-283 potently inhibits B-RAFV600E-activated ERK phosphorylation and cell proliferation. It demonstrates selective cytotoxicity and preferentially inhibits proliferation of cancer cells harbouring B-RAFV600E and EGFR mutation/amplification. In B-RAFV600E CRC cell lines, BGB-283 effectively inhibits the ...
T78879	CXCR4-IN-2	CXCR	Autophagy; GPCR/G Protein; Immunology/Inflammation
	CXCR4-IN-2（compound A1）是一款具有抗癌活性的双功能氟化小分子，是CXCR4的强效抑制剂。它对小鼠结直肠癌(CRC)细胞展现出显著的细胞毒性（IC50：60 μg/mL；72小时）和抗增殖能力，能够引导细胞在G2/M期发生阻滞并诱导细胞凋亡(apoptosis)。
T78569	CPT2 Carnitine palmitoyltransferase 2	Apoptosis	Apoptosis
	CPT2 (Carnitine palmitoyltransferase 2) 是一种脂肪酸氧化过程中的酶，它在结直肠癌 (CRC) 预后评估中作为生物标志物。CPT2 通过过表达激活p-p53并增加p53蛋白水平，这有助于抑制肿瘤生长和促进细胞的凋亡。CPT2 缺乏是长链脂肪酸氧化障碍相关的常见遗传性疾病，并且CPT2 的表达降低与多种癌症的发展密切相关，因此，在癌症研究领域具有研究价值。

化合物

Cat.No: T0459

Synonym: Arthrocine,MK-231,舒林酸,Clinoril,Sulindac sulfoxide

Target: COX, Autophagy

Cat.No: T9556

Target: Wnt/beta-catenin

Cat.No: T77519

Synonym: FC116

Target: Apoptosis, Microtubule Associated

Cat.No: T9901A-004

Synonym: IMMU-14,hMN-14,IMMU-100

Cat.No: T72068

Target: Apoptosis, ROS

Cat.No: T76890

Synonym: MCLA 158

Target: EGFR

Cyclosomatostatin Acetate

Cat.No: T21567L

Synonym: Cyclosomatostatin Acetate （84211-54-1 Free base）

Target: Somatostatin

Cat.No: T27163

CDK5 inhibitor 20-223

Cat.No: T36742

Synonym: CDK5 inhibitor 20-223

Cat.No: T71624

Cat.No: T38519

Synonym: Wnt pathway inhibitor 2,YB-0158

Cat.No: T73391

Rineterkib hydrochloride

Cat.No: T36676

Cyclosomatostatin TFA

Cat.No: T75842

Cat.No: T60030

Cat.No: T82414

Synonym: MK-4280

Sulindac sodium

Cat.No: T61585

Cat.No: T61896

Lifirafenib HCl

Cat.No: T69985

Cat.No: T78879

Target: CXCR

Cat.No: T78569

Synonym: Carnitine palmitoyltransferase 2

Target: Apoptosis

Cat. No.	Product Name	Target	Signaling Pathways
T3055	Liensinine Perchlorate	Apoptosis; Others	Apoptosis; Others
	Liensinine Perchlorate 是元莲的成分，可诱导结直肠癌细胞凋亡，具有抗高血压和抗癌活性。
T79933	(−)-N-Hydroxyapiosporamide NHAP	NF-κB	NF-κB
	(−)-N-Hydroxyapiosporamide (NHAP)为生物碱类NF-κB抑制剂，表现出体外及体内抗肿瘤活性，常用于结直肠癌(CRC)研究。

天然产物

Liensinine Perchlorate

Cat.No: T3055

Target: Apoptosis, Others

(−)-N-Hydroxyapiosporamide

Cat.No: T79933

Synonym: NHAP

Target: NF-κB

我们的所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

Copyright © 2015-2024 TargetMol Chemicals Inc. All rights reserved. 沪ICP备20019793号-4

沪公网安备 31010602006700号

沪公网安备 31010602006700号

TargetMol Loading

联系我们

电话：

400-820-0310

邮箱：

service@tsbiochem.com

QQ：

2881945090（终端用户）

2885109491（经销商）

经销：

终端：

地址：

上海市静安区江场三路238号8楼